Phytoestrogen and fiber intakes in relation to incident vasomotor symptoms: Results from the Study of Women's Health Across the Nation

Menopause

Volumn 20, Issue 3, 2013, Pages 308-314

  Gold, Ellen B ^a   Leung, Katherine ^b   Crawford, Sybil L ^b   Huang, Mei Hua ^c   Waetjen, L Elaine ^a   Greendale, Gail A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diet; Menopause; Phytoestrogens; Race ethnicity; Vasomotor symptoms

Indexed keywords

COUMESTROL; ISOFLAVONE; LIGNAN; PHYTOESTROGEN; ISOFLAVONE DERIVATIVE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FIBER; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MENOPAUSE; PREMENOPAUSE; RISK; VASOMOTOR DISORDER; CLIMACTERIUM; DIET; DIETARY FIBER; DRUG EFFECT; ETHNIC GROUP; HOT FLUSH; LONGITUDINAL STUDY; MIDDLE AGED; QUESTIONNAIRE; RACE; STATISTICAL MODEL; SWEATING; WOMEN'S HEALTH;

ADULT; CONTINENTAL POPULATION GROUPS; COUMESTROL; DIET; DIETARY FIBER; ETHNIC GROUPS; FEMALE; HOT FLASHES; HUMANS; ISOFLAVONES; LIGNANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; PERIMENOPAUSE; PHYTOESTROGENS; PREMENOPAUSE; QUESTIONNAIRES; SWEATING; WOMEN'S HEALTH;

EID: 84874763354     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31826d2f43     Document Type: Article

References (55)

1. The North American Menopause Society. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/ Wulf H. Utian Translational Science Symposium in Chicago, IL, October 2010. Menopause 2011;18: 732-753.
2. Murkies AL, Lombard C, Strauss, et al. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995;21: 189-195.
3. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91: 6-11.
4. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7: 105-111.
5. Upmalis DH, Lobo R, Bradley L, et al. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized placebo controlled study. Menopause 2000; 7: 236-242.
6. Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized placebo-controlled study. Menopause 2002;9: 329-334.
7. Crisafulli A, Marini H, Bitto A, et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause 2004;11: 400-404.
8. D'Anna R, Cannata ML, Martini H, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebocontrolled study. Menopause 2009;16: 301-306.
9. Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause 2009;16: 141-148.
10. Jenks B, Uchiyama S, Iwashita S, et al. Efficacy and safety of natural Sequol supplement in US postmenopausal women [Abstract P-22]. 1st Annual Meeting of The North American Menopause Society. Menopause 2010;17: 1229.
11. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health 2006; 96: 1226-1235.
12. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor A. Endocrinology 1998;139: 4252-4263.
13. Takeuchi S, Takahashi T, Sawada Y, et al. Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol Pharm Bull 2009;32: 195-202.
14. Carreau C, Flouriot G, Bennetau-Pelissero C, Potier M. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ER > transcriptional activation in human breast cancer cells. J Steroid Biochem Mol Biol 2008;110: 176-185.
15. Pilxa'ková L, Rieansk I, Jagla F. The physiological actions of isoflavone phytoestrogens. Physiol Res 2010;59: 651-664.
16. Turner JV, Agatonovic-Kustrin S, Glass BD. Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci 2007;96: 1879-1885.
17. Magee PJ, Rowland IR. Phytoestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004; 91: 513-531.
18. Mortensen A, Kulling SE, Schwartz H, et al. Analytical and compositional aspects of isoflavones in food and their biological effects. Mol Nutr Food Res 2009;53(Suppl 2): S266-S309.
19. Lewis JE, Nickell LA, Thompson LU, et al. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 2006;13: 631-642.
20. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol 2000;18: 1068-1074.
21. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001;8: 17-26.
22. Burke GL, Legault C, Anthony M, et al. Soy protein and isoflavone effects on vasomotor symptoms in peri- and post-menopausal women: the Soy Estrogen Alternative Study. Menopause 2003;10: 147-153.
23. Verhoeven MO, van der Mooren MJ, van de Weijer PHM, et al. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12- week randomized, placebo-controlled, double-blind study. Menopause 2005;12: 412-426.
24. Adlercreutz H, Hockerstedt K, Bannwart C. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987;27: 1135-1144.
25. Aubertin-Leheudre M, Gorbach S, Woods M, et al. Fab/fiber intakes and sex hormones in healthy premenopausal women in USA. J Steroid Biochem Mol Biol 2008;112: 32-39.
26. Bagga D, Ashley JM, Geffrey SP, et al. Effects of a very low fat, high fiber diet on serum hormones and menstrual function. Implications for breast cancer prevention. Cancer 1995;76: 2491-2496.
27. Gaskins AJ, Mumford SL, Zhang C, et al. Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr 2009;90: 1061-1069.
28. Gann PH, Chatterton RT, Gapstur SM, et al. The effects of a low-fat/ high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (The Diet and Hormone Study). Cancer 2003;98: 1870-1879.
29. Goldin BR, Woods MN, Spiegelman DL, et al. The effect of dietary fat and fiber on serum estrogen concentrations in premenopausal women under controlled dietary conditions. Cancer 1994;74(Suppl 3): 1125-1131.
30. Kaneda N, Nagata C, Kabuto M, Shimizu H. Fat and fiber intakes in relation to serum estrogen concentration in premenopausal Japanese women. Nutr Cancer 1997;27: 279-283.
31. Mumford SL, Schisterman EF, Siega-Riz AM, et al. Effect of dietary fiber intake on lipoprotein cholesterol levels independent of estradiol in healthy premenopausal women. Am J Epidemiol 2011;173: 145-156.
32. Rose DP, Goldman M, Connolly JM, Strong LE. High-fiber diet reduced serum estrogen concentrations in premenopausal women. Am J Clin Nutr 1991;54: 520-525.
33. Woods MN, Barnett JB, Spiegelman D, et al. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst 1996;88: 1369-1374.
34. Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 1999;91: 529-534.
35. Gold EB, Flatt S, Pierce JP, et al. Dietary factors and vasomotor symptoms in breast cancer survivors, the WHEL Study. Menopause 2006;13: 423-433.
36. Huang M-H, Norris J, Han W, et al. Development of an updated phytoestrogen database for use with the SWAN Food Frequency Questionnaire: intakes and food sources in a community-based, multiethnic cohort study. Nutr Cancer 2012;64: 228Y244.
37. Sowers MF, Crawford SL, Sternfeld B, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, eds. Menopause Biology and Pathobiology, San Diego, CA: Academic Press, 2000: 175-188.
38. Little RJA, Rubin DB. Statistical Analysis with Missing Data, 2nd ed. New York, NY: Wiley, 2002.
39. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124: 453-469.
40. Subar AF, Thompson FE, Kipnis V, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. Am J Epidemiol 2001; 154: 1089-1099.
41. Block G, Thompson F, Hartman AM, Larkin FA, Guire KE. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992;92: 686-693.
42. Block G, Norris JC, Mandel RM, DiSogra C. Sources of energy and six nutrients in diets of low-income Hispanic-American women and children: quantitative data from the HHANES survey, 1982-1984. J Am Diet Assoc 1995;95: 195-208.
43. Reinli K, Block G. Phytoestrogen content of foodsVa compendium of literature values. Nutr Cancer 1996;26: 123-148.
44. Greendale GA, Huang M-H, Leung K, et al. Dietary phytoestrogen intakes and cognitive function during the menopause transition: results from the Study of Women's Health Across the Nation Phytoestrogen Study. Menopause 2012;19: 894Y903.
45. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1: 385-401.
46. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med 1988;50: 510-519.
47. Coghlin J, Hammond SK, Gann PH. Development of epidemiologic tools for measuring environmental tobacco smoke exposure. Am J Epidemiol 1989;130: 696-704.
48. Baecke JAH, Burema J, Fritjers JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36: 936-942.
49. Sternfeld B, Ainsworth BA, Quesenberry CP Jr. Physical activity patterns in a diverse population of women. Prev Med 1999;28: 313-323.
50. Sheldon C, Williamson G. Perceived stress in a probability sample of the United States. In: Spacan S, Oskam S, eds. The Social Psychology of Health. Newbury Park, CA: Sage, 1988: 31-67.
51. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118: 1-120.
52. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32: 705-714.
53. Molenberghs G, Verbeke G. Models for Discrete Longitudinal Data. New York, NY: Springer Science + Business Media, 2005.
54. Kuss O, McLerran D. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 2007;87: 262-269.
55. Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 2008;15: 841-847.